Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 13, 2026 18:13 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
July 10, 2026 13:34 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca (ERAS) Faces Securities Class Action After Stock Declines 48% on Drug Safety and IP Concerns-- HBSS

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
July 09, 2026 09:19 ET | Source: Bernstein Liebhard LLP

ERASCA, INC. (ERAS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Erasca, Inc. Investors of Upcoming Deadline

Erasca Shareholders Between January 14, 2025 and April 26, 2026 - Contact Bernstein Liebhard For More Information Regarding Lawsuit
July 08, 2026 14:17 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
July 06, 2026 16:43 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca (ERAS) Faces Securities Class Action After Stock Declines 48% on Drug Safety and IP Concerns-- HBSS

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
July 03, 2026 14:19 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss -- HBSS

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
June 30, 2026 19:10 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss – Hagens Berman

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
June 26, 2026 18:31 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss – Hagens Berman

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
June 24, 2026 20:22 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss – Hagens Berman

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.
June 22, 2026 15:04 ET | Source: Hagens Berman Sobol Shapiro LLP

Erasca, Inc. (ERAS) Faces Securities Class Action Amid Patient Death, Intellectual Property Questions, $2.8 Billion Market Cap Loss – Hagens Berman

Investors who lost money in ERAS after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.